Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 23:3:39.
doi: 10.1186/s41927-019-0086-3. eCollection 2019.

Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006-2016

Jessica Walsh  1 , Theresa Hunter  2 , Krista Schroeder  2 , David Sandoval  2 , Rebecca Bolce  2
Affiliations

Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006-2016

Jessica Walsh et al. BMC Rheumatol. .

Abstract

Background: There has been much variation between epidemiological studies that report the prevalence of ankylosing spondylitis (AS). This study aimed to analyze the diagnostic prevalence rates and treatment patterns of male and female AS patients in the United States adult insured population from 2006 to 2016.

Methods: Trends in AS prevalence were calculated for the 11-year period covering January 1, 2006 to December 31, 2016. Adult (18+ years old) AS patients were included in this retrospective analysis of medical and pharmacy claims data from the IBM Marketscan Commercial, Medicaid and Medicare-Supplemental Claims database. Prevalence was determined as having ≥1 AS diagnostic codes (ICD-9:720.0; ICD-10:M45.x). Trends in treatment patterns were also analyzed and stratified by gender.

Results: The AS prevalence increased from 0.04 to 0.09% from 2006 to 2016. The mean age between 2006 and 2016 ranged from 49.52-50.00 years. In 2006, approximately 40% of AS patients were female, while in 2016 over 47% of AS patients were female. Rates of use of TNF inhibitors and oral glucocorticoids increased, while NSAIDs and non-biologic DMARDs (sulfasalazine & methotrexate) rates decreased. Opioid use rates were stable. In 2016, males were more likely to be prescribed biologics, while females were more likely to be prescribed methotrexate, sulfasalazine, NSAIDs, muscle relaxants, anticonvulsants, opioids, and glucocorticoids.

Conclusions: The prevalence of AS diagnosis codes more than doubled between 2006 and 2016, but the very low prevalence suggests that AS continues to be underdiagnosed and under-addressed in routine clinical practice. Despite the increase in female AS patients, females were less likely to be prescribed biologics compared to male AS patients.

Keywords: Ankylosing spondylitis; Prevalence; Treatment patterns.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Medication use among male and female as patients in 2016
Fig. 2
Fig. 2
Ankylosing spondylitis prevalence trends stratified by gender (2006–2016)
Fig. 3
Fig. 3
Trends in treatment patterns among as patients, 2006–2016
See this image and copyright information in PMC

References

    1. Sieper J, Braun J, Dougados M, Baeten D. Axial spondyloarthritis. Nat Rev Dis Primers. 2015;1:15013. doi: 10.1038/nrdp.2015.13. - DOI - PubMed
    1. Boonen A, Brinkhuizen T, Landewé R, et al. Impact of ankylosing spondylitis on sick leave, presenteeism, and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis. 2010;69:1123–1128. doi: 10.1136/ard.2009.116764. - DOI - PubMed
    1. Kotsis K, Voulgari PV, Dross AA, Carvalho AF, Hyphantis T. Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review. Expert Rev Pharmacoeconomic Outcomes Res. 2014;14:857–872. doi: 10.1586/14737167.2014.957679. - DOI - PubMed
    1. Carter ET, McKenna CH, Brian DD, et al. Epidemiology of ankylosing spondylitis in Rochester, Minnesota, 1935-1973. Arthritis Rheum. 1979;22:365–370. doi: 10.1002/art.1780220408. - DOI - PubMed
    1. Carbone LD, Cooper C, Michet CJ, et al. Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing? Arthritis Rheum. 1992;35:1476–1482. doi: 10.1002/art.1780351211. - DOI - PubMed